Approval · Notice of Compliance 38151 · 2026
NDUVRA: Notice of Compliance 38151
Issued August 20, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38151
- Date
- August 20, 2026
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of new indication: for the topical treatment of moderate to severe atopic dermatitis in adult and pediatric patients 2 years of age and older
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NDUVRA | Not yet assigned | — |
Medicinal ingredients
- TAPINAROF 1 PER